These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 7173299)
1. Metabolic aspects of maximal exercise performance after slow release metoprolol and after atenolol. Folgering HT; Borm JF; van Haaren RH Eur J Clin Pharmacol; 1982 Oct; 23(4):283-8. PubMed ID: 7173299 [TBL] [Abstract][Full Text] [Related]
2. Exercise metabolism in healthy volunteers taking atenolol, high and low doses of metoprolol CR/Z0K, and placebo. Head A; Maxwell S; Kendall MJ; Eagles C Br J Clin Pharmacol; 1994 Dec; 38(6):499-504. PubMed ID: 7888287 [TBL] [Abstract][Full Text] [Related]
3. Maximal exercise power after a single dose of metoprolol and of slow-release metoprolol. Folgering H; van Bussel M Eur J Clin Pharmacol; 1980 Oct; 18(3):225-9. PubMed ID: 7439241 [TBL] [Abstract][Full Text] [Related]
4. Comparison of two long-acting preparations of metoprolol with conventional metoprolol and atenolol in healthy men during chronic dosing. Freestone S; Silas JH; Lennard MS; Ramsay LE Br J Clin Pharmacol; 1982 Nov; 14(5):713-8. PubMed ID: 7138751 [TBL] [Abstract][Full Text] [Related]
5. Effects of a week's beta-adrenoceptor blockade with atenolol and metoprolol CR/ZOK on the response to exercise in healthy women aged 50 to 70 years. Patrick J; Bassey J; Morrant J; Macdonald I J Clin Pharmacol; 1990 Feb; 30(S2):S108-16. PubMed ID: 2312773 [TBL] [Abstract][Full Text] [Related]
6. The effect of pretreatment with cimetidine on the bioavailability and disposition of atenolol and metoprolol. Houtzagers JJ; Streurman O; Regårdh CG Br J Clin Pharmacol; 1982 Jul; 14(1):67-72. PubMed ID: 6125199 [TBL] [Abstract][Full Text] [Related]
7. The comparative beta-adrenoceptor blocking effects of penbutolol, atenolol and sustained-release metoprolol in healthy volunteers. Mucklow JC; Kuhn S Eur J Clin Pharmacol; 1984; 27(3):269-73. PubMed ID: 6510453 [TBL] [Abstract][Full Text] [Related]
8. The effects of combined treatment with beta 1-selective receptor antagonists and lipid-lowering drugs on fat metabolism and measures of fatigue during moderate intensity exercise: a placebo-controlled study in healthy subjects. Eagles CJ; Kendall MJ Br J Clin Pharmacol; 1997 Mar; 43(3):291-300. PubMed ID: 9088584 [TBL] [Abstract][Full Text] [Related]
9. Controlled-release metoprolol compared with atenolol in asthmatic patients: interaction with terbutaline. Löfdahl CG; Dahlöf C; Westergren G; Olofsson B; Svedmyr N Eur J Clin Pharmacol; 1988; 33 Suppl():S25-32. PubMed ID: 2836204 [TBL] [Abstract][Full Text] [Related]
10. The effects of a cardioselective (metoprolol) and a nonselective (propranolol) beta-adrenergic blocker on the response to dynamic exercise in normal men. Sklar J; Johnston GD; Overlie P; Gerber JG; Brammell HL; Gal J; Nies AS Circulation; 1982 May; 65(5):894-9. PubMed ID: 7074750 [TBL] [Abstract][Full Text] [Related]
11. Effect of beta-adrenergic blockade on hyperventilation and exercise tolerance in emphysema. Butland RJ; Pang JA; Geddes DM J Appl Physiol Respir Environ Exerc Physiol; 1983 May; 54(5):1368-73. PubMed ID: 6863097 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of importance of central effects of atenolol and metoprolol measured by heart rate variability during mental performance tasks, physical exercise, and daily life in stable postinfarct patients. Tuininga YS; Crijns HJ; Brouwer J; van den Berg MP; Man in't Veld AJ; Mulder G; Lie KI Circulation; 1995 Dec; 92(12):3415-23. PubMed ID: 8521562 [TBL] [Abstract][Full Text] [Related]
13. Beta-adrenoceptor blockade and CNS-related subjective symptoms: a randomized, double-blind, placebo-controlled comparison of metoprolol CR/ZOK, atenolol and propranolol LA in healthy subjects. Dimenäs E; Kerr D; Macdonald I J Clin Pharmacol; 1990 Feb; 30(S2):S103-7. PubMed ID: 1968912 [TBL] [Abstract][Full Text] [Related]
14. Effects on exercise tachycardia during forty-eight hours of a series of doses of atenolol, sotalol, and metoprolol. Harron DW; Balnave K; Kinney CD; Wilson R; Russell CJ; Shanks RG Clin Pharmacol Ther; 1981 Mar; 29(3):295-302. PubMed ID: 7471600 [TBL] [Abstract][Full Text] [Related]
15. Ambulatory blood pressure during once-daily randomised double-blind administration of atenolol, metoprolol, pindolol, and slow-release propranolol. Floras JS; Jones JV; Hassan MO; Sleight P Br Med J (Clin Res Ed); 1982 Nov; 285(6352):1387-92. PubMed ID: 6814568 [TBL] [Abstract][Full Text] [Related]
16. A comparison of 100 mg atenolol and 100 mg metoprolol once a day at rest and during exercise in hypertensives. Nilsson OR; Atterhög JH; Castenfors J; Jorfelt L; Karlberg BE; Thulin T; Tolagen K; Wettre S; Ohman KP Acta Med Scand; 1984; 216(3):301-7. PubMed ID: 6388253 [TBL] [Abstract][Full Text] [Related]
17. Acute response to submaximal and maximal exercise consequent to beta-adrenergic blockade: implications for the prescription of exercise. Wilmore JH; Freund BJ; Joyner MJ; Hetrick GA; Hartzell AA; Strother RT; Ewy GA; Faris WE Am J Cardiol; 1985 Apr; 55(10):135D-141D. PubMed ID: 3993545 [TBL] [Abstract][Full Text] [Related]
18. A comparison of once daily atenolol and metoprolol SA in mild to moderate hypertension. Morley CA; Cavalcanti C; Perrins EJ; Sutton R Br J Clin Pharmacol; 1983 Jun; 15(6):715-7. PubMed ID: 6347229 [TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics and pharmacodynamics of controlled-release metoprolol: a comparison with atenolol. Blomqvist I; Westergren G; Sandberg A; Jonsson UE; Lundborg P Eur J Clin Pharmacol; 1988; 33 Suppl():S19-24. PubMed ID: 3371390 [TBL] [Abstract][Full Text] [Related]
20. Differentiation of hemodynamic, humoral and metabolic responses to beta 1- and beta 2-adrenergic stimulation in man using atenolol and propranolol. McLeod AA; Brown JE; Kuhn C; Kitchell BB; Sedor FA; Williams RS; Shand DG Circulation; 1983 May; 67(5):1076-84. PubMed ID: 6299612 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]